Showing 1 - 10 results of 10 for search 'Wan‐Hee Yoo', query time: 0.05s Refine Results
  1. 1
    Gold threads around the sacroiliac joints: traces of attempts to relieve pain in a case of advanced ankylosing spondylitis

    Gold threads around the sacroiliac joints: traces of attempts to relieve pain in a case of advanced ankylosing spondylitis by Wan-Hee Yoo, Yunjung Choi

    Published 2022-11-01
    Get full text
    Article
  2. 2
    4‐Phenylbutyric acid, a potent endoplasmic reticulum stress inhibitor, attenuates the severity of collagen‐induced arthritis in mice via inhibition of proliferation and inflammatory responses of synovial fibroblasts

    4‐Phenylbutyric acid, a potent endoplasmic reticulum stress inhibitor, attenuates the severity of collagen‐induced arthritis in mice via inhibition of proliferation and inflammator... by Yunjung Choi, Eun‐Gyeong Lee, Ji‐Hyeon Jeong, Wan‐Hee Yoo

    Published 2021-07-01
    Get full text
    Article
  3. 3
    Sudden Onset of IgA Vasculitis Affecting Vital Organs in Adult Patients following SARS-CoV-2 Vaccines

    Sudden Onset of IgA Vasculitis Affecting Vital Organs in Adult Patients following SARS-CoV-2 Vaccines by Yunjung Choi, Chang Hun Lee, Kyoung Min Kim, Wan-Hee Yoo

    Published 2022-06-01
    Get full text
    Article
  4. 4
    Ethyl acetate fraction from Angelica sinensis inhibits IL-1β-induced rheumatoid synovial fibroblast proliferation and COX-2, PGE2, and MMPs production

    Ethyl acetate fraction from Angelica sinensis inhibits IL-1β-induced rheumatoid synovial fibroblast proliferation and COX-2, PGE2, and MMPs production by Won-Seok Lee, Jin-Han Lim, Myung-Soon Sung, Eun-Gyeong Lee, Yoo-Jeong Oh, Wan-Hee Yoo

    Published 2014-01-01
    Get full text
    Article
  5. 5
    Ethyl acetate fraction from Cudrania tricuspidata inhibts IL-1β-induced rheumatoid synovial fibroblast proliferation and MMPs, COX-2 and PGE2 production

    Ethyl acetate fraction from Cudrania tricuspidata inhibts IL-1β-induced rheumatoid synovial fibroblast proliferation and MMPs, COX-2 and PGE2 production by Eun-Gyeong Lee, Sang-ll Lee, Han-Jung Chae, Seoung Ju Park, Yong Chul Lee, Wan-Hee Yoo

    Published 2010-01-01
    Get full text
    Article
  6. 6
    Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis

    Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis by Josef S. Smolen, Young Mo Kang, Wan-Hee Yoo, Paul Emery, Michael E. Weinblatt, Edward C. Keystone, Mark C. Genovese, Gihyun Myung, Inyoung Baek, Jeehoon Ghil

    Published 2020-08-01
    Get full text
    Article
  7. 7
    Relationship between decreased lower extremity muscle mass and knee pain severity in both the general population and patients with knee osteoarthritis: Findings from the KNHANES V 1-2.

    Relationship between decreased lower extremity muscle mass and knee pain severity in both the general population and patients with knee osteoarthritis: Findings from the KNHANES V... by Yun-Hong Cheon, Hyun-Ok Kim, Young Sun Suh, Min Gyo Kim, Wan-Hee Yoo, Rock Bum Kim, Hyun-Su Yang, Sang-Il Lee, Ki-Soo Park

    Published 2017-01-01
    Get full text
    Article
  8. 8
    Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data

    Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data by Wan-Hee Yoo, Young Mo Kang, Dong Wook Kim, Eun Ha Kang, Yeon-Ah Lee, Chang-Hee Suh, Yoon-Kyoung Sung, Sang-Hoon Lee, Dong-Ha Gu, Jiwon Lee, Jung-Yoon Choe

    Published 2022-12-01
    Get full text
    Article
  9. 9
    Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study

    Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC... by Min-Chan Park, Hiroaki Matsuno, Jinseok Kim, Sung-Hwan Park, Sang-Heon Lee, Yong-Beom Park, Yun Jong Lee, Sang-Il Lee, Won Park, Dong Hyuk Sheen, Jung-Yoon Choe, Chan-Bum Choi, Seung-Jae Hong, Chang-Hee Suh, Shin-Seok Lee, Hoon-Suk Cha, Bin Yoo, Jin-Wuk Hur, Geun-Tae Kim, Wan-Hee Yoo, Han Joo Baek, Kichul Shin, Seung Cheol Shim, Hyung-In Yang, Hyun Ah Kim, Kyung-Su Park, In Ah Choi, Jisoo Lee, Masato Tomomitsu, Seonghye Shin, Jiyoon Lee, Yeong Wook Song

    Published 2019-05-01
    Get full text
    Article
  10. 10
    Interleukin-7 Induces Osteoclast Formation via STAT5, Independent of Receptor Activator of NF-kappaB Ligand

    Interleukin-7 Induces Osteoclast Formation via STAT5, Independent of Receptor Activator of NF-kappaB Ligand by Jin-Hee Kim, Jin-Hee Kim, Ji Hyun Sim, Sunkyung Lee, Min A. Seol, Min A. Seol, Min A. Seol, Sang-Kyu Ye, Sang-Kyu Ye, Sang-Kyu Ye, Sang-Kyu Ye, Hyun Mu Shin, Hyun Mu Shin, Hyun Mu Shin, Hyun Mu Shin, Eun Bong Lee, Eun Bong Lee, Yun Jong Lee, Yun Jung Choi, Wan-Hee Yoo, Jin Hyun Kim, Wan-Uk Kim, Dong-Sup Lee, Dong-Sup Lee, Dong-Sup Lee, Dong-Sup Lee, Jin-Hong Kim, Insoo Kang, Seong Wook Kang, Hang-Rae Kim, Hang-Rae Kim, Hang-Rae Kim, Hang-Rae Kim

    Published 2017-10-01
    Get full text
    Article

Search Tools: